FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
PMA: P190019
·
Supplement: S018
·
Decision Mar 2, 2023
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Trade Name
- Ranger Paclitaxel-Coated PTA Balloon Catheter
- PMA Number
- P190019
- Supplement Number
- S018
- Device Class
- FDA Class 3
- Product Code
- ONU
- Generic Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- March 2, 2023
- Date Received
- December 7, 2022
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for a change to an alternate supplier of an equivalent resin used as the middle layer in the tri-layer inner component of your stents delivery system.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |